Stephanie R Land1,2, Graham W Warren3,4, Jennifer L Crafts5, Dorothy K Hatsukami6, Jamie S Ostroff7, Gordon B Willis2, Veronica Y Chollette2, Sandra A Mitchell2, Jasmine N M Folz5, James L Gulley8, Eva Szabo9, Thomas H Brandon10, Sonia A Duffy11, Benjamin A Toll12. 1. Tobacco Control Research Branch, Behavioral Research Program, National Cancer Institute, Bethesda, Maryland. 2. Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD. 3. Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina. 4. Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina. 5. Westat Inc, Rockville, Maryland. 6. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. 7. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York. 8. Center for Cancer Research, National Cancer Institute, Bethesda, MD. 9. Division of Cancer Prevention, National Cancer Institute, Rockville, MD. 10. Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, Florida. 11. College of Nursing, Ohio State University, Columbus, Ohio. 12. Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
Abstract
BACKGROUND: To the authors' knowledge, there are currently no standardized measures of tobacco use and secondhand smoke exposure in patients diagnosed with cancer, and this gap hinders the conduct of studies examining the impact of tobacco on cancer treatment outcomes. The objective of the current study was to evaluate and refine questionnaire items proposed by an expert task force to assess tobacco use. METHODS: Trained interviewers conducted cognitive testing with cancer patients aged ≥21 years with a history of tobacco use and a cancer diagnosis of any stage and organ site who were recruited at the National Institutes of Health Clinical Center in Bethesda, Maryland. Iterative rounds of testing and item modification were conducted to identify and resolve cognitive issues (comprehension, memory retrieval, decision/judgment, and response mapping) and instrument navigation issues until no items warranted further significant modification. RESULTS: Thirty participants (6 current cigarette smokers, 1 current cigar smoker, and 23 former cigarette smokers) were enrolled from September 2014 to February 2015. The majority of items functioned well. However, qualitative testing identified wording ambiguities related to cancer diagnosis and treatment trajectory, such as "treatment" and "surgery"; difficulties with lifetime recall; errors in estimating quantities; and difficulties with instrument navigation. Revisions to item wording, format, order, response options, and instructions resulted in a questionnaire that demonstrated navigational ease as well as good question comprehension and response accuracy. CONCLUSIONS: The Cancer Patient Tobacco Use Questionnaire (C-TUQ) can be used as a standardized item set to accelerate the investigation of tobacco use in the cancer setting. Cancer 2016;122:1728-34.
BACKGROUND: To the authors' knowledge, there are currently no standardized measures of tobacco use and secondhand smoke exposure in patients diagnosed with cancer, and this gap hinders the conduct of studies examining the impact of tobacco on cancer treatment outcomes. The objective of the current study was to evaluate and refine questionnaire items proposed by an expert task force to assess tobacco use. METHODS: Trained interviewers conducted cognitive testing with cancerpatients aged ≥21 years with a history of tobacco use and a cancer diagnosis of any stage and organ site who were recruited at the National Institutes of Health Clinical Center in Bethesda, Maryland. Iterative rounds of testing and item modification were conducted to identify and resolve cognitive issues (comprehension, memory retrieval, decision/judgment, and response mapping) and instrument navigation issues until no items warranted further significant modification. RESULTS: Thirty participants (6 current cigarette smokers, 1 current cigar smoker, and 23 former cigarette smokers) were enrolled from September 2014 to February 2015. The majority of items functioned well. However, qualitative testing identified wording ambiguities related to cancer diagnosis and treatment trajectory, such as "treatment" and "surgery"; difficulties with lifetime recall; errors in estimating quantities; and difficulties with instrument navigation. Revisions to item wording, format, order, response options, and instructions resulted in a questionnaire that demonstrated navigational ease as well as good question comprehension and response accuracy. CONCLUSIONS: The CancerPatientTobacco Use Questionnaire (C-TUQ) can be used as a standardized item set to accelerate the investigation of tobacco use in the cancer setting. Cancer 2016;122:1728-34.
Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring Journal: Value Health Date: 2011-10-10 Impact factor: 5.725
Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring Journal: Value Health Date: 2011-10-13 Impact factor: 5.725
Authors: J Lee Westmaas; Christina C Newton; Victoria L Stevens; W Dana Flanders; Susan M Gapstur; Eric J Jacobs Journal: J Clin Oncol Date: 2015-04-20 Impact factor: 44.544
Authors: Stephen Boorjian; Janet E Cowan; Badrinath R Konety; Janeen DuChane; Ashutosh Tewari; Peter R Carroll; Christopher J Kane Journal: J Urol Date: 2007-03 Impact factor: 7.450
Authors: Elizabeth L Kaufman; Judith S Jacobson; Dawn L Hershman; Manisha Desai; Alfred I Neugut Journal: J Clin Oncol Date: 2008-01-20 Impact factor: 44.544
Authors: Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell Journal: J Clin Oncol Date: 2009-03-16 Impact factor: 44.544
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Anne Brédart; Alexia Marrel; Linda Abetz-Webb; Kathy Lasch; Catherine Acquadro Journal: Health Qual Life Outcomes Date: 2014-02-05 Impact factor: 3.186
Authors: Emily B Peterson; David B Portnoy; Kelly D Blake; Gordon Willis; Katy Trundle; Andrew R Caporaso; Aaron Maitland; Annette R Kaufman Journal: Nicotine Tob Res Date: 2019-10-26 Impact factor: 4.244
Authors: Laurie E Steffen McLouth; Thomas W Lycan; Beverly J Levine; Jennifer Gabbard; Jimmy Ruiz; Michael Farris; Stefan C Grant; Nicholas M Pajewski; Kathryn E Weaver; W Jeffrey Petty Journal: Clin Lung Cancer Date: 2019-11-29 Impact factor: 4.785
Authors: Jamie S Ostroff; Elyse R Park; Brett M Goshe; Autumn W Rasmussen; Lynne I Wagner; JoRean D Sicks; Ilana F Gareen; Ruth C Carlos; Benjamin A Herman; Angela Wangari Walter; Susan Regan; Douglas E Levy; Irene Mahon; Alona Muzikansky; Jordan M Neil; Michelle Lui; Deepika Dilip; Laura Malloy; Irina Gonzalez; Lucy Finkelstein-Fox; Caitlin McCann; Elissa Perez Journal: BMC Public Health Date: 2022-07-15 Impact factor: 4.135
Authors: Elyse R Park; Giselle K Perez; Susan Regan; Alona Muzikansky; Douglas E Levy; Jennifer S Temel; Nancy A Rigotti; William F Pirl; Kelly E Irwin; Ann H Partridge; Mary E Cooley; Emily R Friedman; Julia Rabin; Colin Ponzani; Kelly A Hyland; Susan Holland; Sarah Borderud; Kim Sprunck; Diana Kwon; Lisa Peterson; Jacob Miller-Sobel; Irina Gonzalez; C Will Whitlock; Laura Malloy; Suhana de León-Sanchez; Maureen O'Brien; Jamie S Ostroff Journal: JAMA Date: 2020-10-13 Impact factor: 56.272
Authors: Nosayaba Osazuwa-Peters; Eric Adjei Boakye; Betty Y Chen; Betelihem B Tobo; Mark A Varvares Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-01-01 Impact factor: 6.223
Authors: Tia N Borger; Gabriella E Puleo; Jessica N Rivera Rivera; Devin Montgomery; William R Bowling; Jessica L Burris Journal: Psychol Addict Behav Date: 2021-03-25
Authors: Elisa K Tong; Terri Wolf; David T Cooke; Nathan Fairman; Moon S Chen Journal: Int J Environ Res Public Health Date: 2020-05-06 Impact factor: 3.390